Study on biological activity of two modified anti-tumor peptide of tumstatin

Progress in Biochemistry and Biophysics

Volumn 34, Issue 11, 2007, Pages 1152-1161

  Wang, Shu Jing ^a,b,c   Liu, Xing Han ^c   Ji, Yu Bin ^a   Chen, Ning ^a  

^a HARBIN UNIVERSITY OF COMMERCE   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell apoptosis; Cell proliferation; Protein expression; Tumor therapy; Tumstatin

Indexed keywords

ESCHERICHIA COLI; MUS;

EID: 39149113762     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Saus J, Wieslander J, Langeveld J P, et al. Identification of the goodpasture antigen as the alpha 3 (IV) chain of collagen IV. J Biol Chem, 1988, 263 (26): 13374-13380
2. Maeshima Y, Colorado P C, Torre A, et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem, 2000, 275 (28): 21340-21348
3. Wang S J, Lui X H. Chem Life, 2004, 24(2): 128-130
4. Floquet N, Pasco S, Ramont L, et al. The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J Biol Chem, 2004, 279 (3): 2091-2100
5. Yu Q, Zhou L Y, Lin X S, et al. Chin J Bioc hem mol Biol, 2004, 20 (4): 467-472
6. Wang S J, Liu Y, Lin X S, et al. Chin J Biochem Mol Biol, 2005, 21 (3): 322-328
7. Kalluri R. Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb Symp Quant Biol, 2002, 67: 255-266
8. Maeshima Y, Colorado P C, Kalluri R. Two RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem, 2000, 275 (31): 23745-23750
9. Maeshima Y, Yerramalla U L, Dhanabal M, et al. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol Chem, 2001, 276 (34): 31959-31968
10. Maeshima Y, Manfredi M, Reimer C, et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem, 2001, 276(18): 15240-15248
11. Maeshima Y, Sudhakar A, Lively J C, et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 2002, 295 (5552): 140-143